Arrowhead Pharmaceuticals Inc. (ARWR)
NASDAQ · Healthcare
Arrowhead Pharmaceuticals Inc. Revenue 2011–2025
Arrowhead Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arrowhead Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 73.7 M, a 86.41% decrease year-over-year.
- Arrowhead Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 908.2 M, a 14909.85% increase year-over-year.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2025 was 829.4 M, a 23258.15% increase from 2024.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2024 was 3.6 M, a 98.52% decrease from 2023.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2023 was 240.7 M, a 1.03% decrease from 2022.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2022 was 243.2 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arrowhead Pharmaceuticals Inc. Market Cap — FAQ
Arrowhead Pharmaceuticals Inc. (ARWR) market cap over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARWR's market cap history?
The chart and table above show Arrowhead Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.